These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 1556889

  • 1. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P, Murry T, Swenson M, Woodson GE.
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG, Hunt EJ, Charles DA, Lang AE.
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP, Morrison MD.
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P, Marion MH, Perrin A, Fresnel-Elbaz E.
    Ann Otolaryngol Chir Cervicofac; 1991 Jun; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [Abstract] [Full Text] [Related]

  • 7. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia.
    Witsell DL, Weissler MC, Donovan MK, Howard JF, Martinkosky SJ.
    Laryngoscope; 1994 Jan; 104(1 Pt 1):8-11. PubMed ID: 8295461
    [Abstract] [Full Text] [Related]

  • 8. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD, Rontal M, Rolnick M, Aronson AE, Mistura K.
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S, Saeseow P, Taweesaengsuksakul R, Kharmwan S, Srirompotong S.
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [Abstract] [Full Text] [Related]

  • 10. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL, Irish JC, Adams SG, Durkin LC, Hunt EJ.
    J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
    [Abstract] [Full Text] [Related]

  • 11. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY, Lai CC, Wu PY, Huang HH.
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [Abstract] [Full Text] [Related]

  • 12. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ.
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [Abstract] [Full Text] [Related]

  • 13. Perceptual-acoustic relationships in spasmodic dysphonia.
    Zwirner P, Murry T, Woodson GE.
    J Voice; 1993 Jun; 7(2):165-71. PubMed ID: 8353631
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
    Paniello RC, Barlow J, Serna JS.
    Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
    [Abstract] [Full Text] [Related]

  • 15. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL, Adams SG, Irish JC, Durkin LC, Hunt EJ, Charlton MP.
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND, Wodchis WP, Spak C, Kileny PR.
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [Abstract] [Full Text] [Related]

  • 17. Increased stability of airflow following botulinum toxin injection.
    Finnegan EM, Luschei ES, Gordon JD, Barkmeier JM, Hoffman HT.
    Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK, Jiang J, Ford CN.
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [Abstract] [Full Text] [Related]

  • 19. Effects of type II thyroplasty on adductor spasmodic dysphonia.
    Sanuki T, Yumoto E, Minoda R, Kodama N.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
    [Abstract] [Full Text] [Related]

  • 20. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
    Chen W, Woo P, Murry T.
    J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.